Lonza will continue to sponsor the conservation of horseshoe crabs, which are used in endotoxin testing.
Lonza announced on June 14, 2016 that the company plans to continue to sponsor through 2016 horseshoe crab conservation initiatives by the Ecological Research & Development Group (ERDG), who’s primary focus is protection of the world’s four horseshoe crab species. Lonza will sponsor two ERDG projects in 2016 to help raise conservation awareness.
With the sponsorship money, ERDG will broaden the functionality of their recently launched Horseshoe Crab Teacher Toolbox, an online library for educators. ERDG will also initiate a project to eliminate the use of Limulus polyphemus as bait in conch and eel fishing, by implementing bait-saving gear and developing alternative baits. Limulus polyphemus, a species of horseshoe crab from which Limulus Amebocyte Lystate (LAL) is extracted for endotoxin testing.
Horseshoe crabs are used in the pharmaceutical industry for endotoxin testing, Lonza said in a press announcement. Endotoxins that are associated with the outer membrane of Gram-negative bacteria can elicit number of undesirable pyrogenic effects in humans and animals, including septic shock, fever, vascular collapse, and even death. According to Lonza, it is vital to screen pharmaceuticals such as vaccines, implantable medical devices, and intravenous drugs and fluids for endotoxin contamination before they are administered to patients.
Source: Lonza
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Drug Solutions Podcast: Emerging Methods of Vaccine Administration and Distribution
June 20th 2023Michael Schrader, CEO and co-founder of Vaxess, discusses the latest on vaccine administration and different ways the pharmaceutical industry can distribute these products with Pharmaceutical Technology editor Jill Murphy.
Exosomes Field Advances with Milestones Achieved by EXO Biologics and ExoXpert
December 4th 2024EXO Biologics and ExoXpert, an EXO Biologics subsidiary, have received GMP certification of a European manufacturing facility for exosomes and have successfully loaded mRNA and DNA payloads into GMP-grade exosomes for drug delivery.